Recently, Svensson et al (2016) [47] showed inhibition of ACC affected NSCLC cell and tumor growth, enhanced cytotoxic effects of chemotherapy, and observed increased activity in K-Ras mutant p53−/− and K-Ras mutant - LKB1−/− mouse models. This evidence concerns the gene KRAS and non-small cell lung carcinoma.